Sitemap
- Nephrology Articles Library
- Access
- Acute Kidney Injury
- Accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Diagnosis and Prognosis in Acute Kidney Injury: A Systematic Review and Meta-analysis
- Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT)
- Acute kidney injury
- Continuous Renal-Replacement Therapy for Acute Kidney Injury
- Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial
- Intensity of renal support in critically ill patients with acute kidney injury
- Intermittent versus continuous renal replacement therapy for acute renal failure in adults
- Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine
- AJKD Core Curriculum
- Biomarkers in nephrology: Core Curriculum 2013
- Cardiovascular Disease and CKD: Core Curriculum 2010
- Critical Care Nephrology: Core Curriculum 2009
- General Medical Care of the Dialysis Patient: Core Curriculum 2013
- Genetic Investigations of Kidney Disease: Core Curriculum 2013
- Home Hemodialysis, Daily Hemodialysis, and Nocturnal Hemodialysis: Core Curriculum 2009
- Interventional Nephrology: Core Curriculum 2009
- Kidney development: core curriculum 2011
- Management of Poisonings: Core Curriculum 2010
- Resistant Hypertension: Core Curriculum 2008
- Therapeutic Plasma Exchange: Core Curriculum 2008
- Toxic Nephropathies: Core Curriculum 2010
- Anemia
- A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
- Correction of anemia with epoetin alfa in chronic kidney disease (CHOIR)
- Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study
- Intravenous Iron in Patients Undergoing Maintenance Hemodialysis
- Normalization of hemoglobin level in patients with chronic kidney disease and anemia
- Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis
- The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
- Bone and Mineral Metabolism
- Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study
- Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis
- Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis (EVOLVE)
- Effects of phosphate binders in moderate CKD
- Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis
- Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
- Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
- Continuous Renal Replacement
- Continuous Renal-Replacement Therapy for Acute Kidney Injury
- Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial
- Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients
- Intermittent versus continuous renal replacement therapy for acute renal failure in adults
- Critical Care Nephrology
- Balanced Crystalloids versus Saline in Critically Ill Adults
- Comparison of two fluid-management strategies in acute lung injury
- Continuous Renal-Replacement Therapy for Acute Kidney Injury
- Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial
- Critical Care Nephrology: Core Curriculum 2009
- Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients
- Intensity of renal support in critically ill patients with acute kidney injury
- Diabetic Kidney Disease
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group
- Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial
- Effects of intensive blood-pressure control in type 2 diabetes mellitus
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy (RENAAL)
- Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
- Modern-Day Clinical Course of Type 1 Diabetes Mellitus After 30 Years’ Duration
- Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications
- The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
- The Pathobiology of Diabetic Complications A Unifying Mechanism
- Diabetic Nephropathy
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- Fluid and Electrolytes
- A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia
- Acid–Base Problems in Diabetic Ketoacidosis
- An integrated view of potassium homeostasis
- Balanced Crystalloids versus Saline in Critically Ill Adults
- Clinical practice guideline on diagnosis and treatment of hyponatraemia
- Diagnosis and treatment of hyponatremia: compilation of the guidelines.
- Differential diagnosis of nongap metabolic acidosis: value of a systematic approach
- Disorders of Plasma Sodium — Causes, Consequences, and Correction
- Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial
- Hyperkalemia in Patients With Chronic Renal Failure
- Hypernatremia
- Hypokalemia
- Hypokalemia
- Hyponatremia
- Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women
- Italian society of nephrology: Management of HK in Kidney disease
- Osmotic demyelination syndrome following correction of hyponatremia
- Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors
- Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate
- Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
- Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study
- Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age
- Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia
- Sodium zirconium cyclosilicate in hyperkalemia
- General Nephrology
- A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies
- A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies
- Accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Diagnosis and Prognosis in Acute Kidney Injury: A Systematic Review and Meta-analysis
- Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT)
- Acute kidney injury
- Alport's syndrome, Goodpasture's syndrome, and type IV collagen
- Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial
- Balanced Crystalloids versus Saline in Critically Ill Adults
- Biomarkers in nephrology: Core Curriculum 2013
- Calciphylaxis
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- Cardiovascular Disease and CKD: Core Curriculum 2010
- Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review
- Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
- Comparison of two fluid-management strategies in acute lung injury
- Critical Care Nephrology: Core Curriculum 2009
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- Effects of an angiotensin-converting–enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the lupus nephritis assessment with rituximab study (LUNAR)
- Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group
- Efficacy of remission-induction regimens for ANCA-associated vasculitis
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- Genetic Investigations of Kidney Disease: Core Curriculum 2013
- Glomerulonephritis
- IgA nephropathy
- Intensity of renal support in critically ill patients with acute kidney injury
- Intensive Supportive Care plus Immunosuppression in IgA Nephropathy
- Interventional Nephrology: Core Curriculum 2009
- Kidney development: core curriculum 2011
- Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial
- Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
- Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis
- Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine
- Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
- Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study
- Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency
- Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
- Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis
- Rituximab versus cyclophosphamide for ANCA-associated vasculitis
- Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis
- Sequential therapies for proliferative lupus nephritis
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications
- Stage IV Chronic Kidney Disease
- The classification of glomerulonephritis in systemic lupus erythematosus revisited
- The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study
- The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- Therapeutic Plasma Exchange: Core Curriculum 2008
- Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
- Tolvaptan in patients with autosomal dominant polycystic kidney disease
- Toxic Nephropathies: Core Curriculum 2010
- Urine Sediment Examination in the Diagnosis and Management of Kidney Disease: Core Curriculum 2019
- Glomerulonephritis
- A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies
- A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the lupus nephritis assessment with rituximab study (LUNAR)
- Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group
- Efficacy of remission-induction regimens for ANCA-associated vasculitis
- Glomerulonephritis
- IgA nephropathy
- Intensive Supportive Care plus Immunosuppression in IgA Nephropathy
- Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial
- Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis
- Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
- Rituximab versus cyclophosphamide for ANCA-associated vasculitis
- Ten common mistakes in the management of lupus nephritis
- The classification of glomerulonephritis in systemic lupus erythematosus revisited
- Hemodialysis
- Blood pressure and mortality among hemodialysis patients
- A randomized, controlled trial of early versus late initiation of dialysis
- Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study
- Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
- Calciphylaxis
- Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis
- Continuous Renal-Replacement Therapy for Acute Kidney Injury
- Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial
- Daily hemodialysis and the outcome of acute renal failure
- Effect of dialysis dose and membrane flux in maintenance hemodialysis
- Effect of dialysis dose and membrane flux in maintenance hemodialysis
- Effect of Dipyridamole plus Aspirin on Hemodialysis Graft Patency
- Effect of Fish Oil Supplementation on Graft Patency and Cardiovascular Events Among Patients With New Synthetic Arteriovenous Hemodialysis Grafts A Randomized Controlled Trial
- Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study
- Functional status of elderly adults before and after initiation of dialysis
- General Medical Care of the Dialysis Patient: Core Curriculum 2013
- Home Hemodialysis, Daily Hemodialysis, and Nocturnal Hemodialysis: Core Curriculum 2009
- In-center hemodialysis six times per week versus three times per week
- Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients
- Intermittent versus continuous renal replacement therapy for acute renal failure in adults
- Intravenous Iron in Patients Undergoing Maintenance Hemodialysis
- Management of Poisonings: Core Curriculum 2010
- Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
- The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial
- The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
- Hyperkalemia
- A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia
- Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial
- Hyperkalemia in Patients With Chronic Renal Failure
- Italian society of nephrology: Management of HK in Kidney disease
- Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors
- Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate
- Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
- Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age
- Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia
- Sodium zirconium cyclosilicate in hyperkalemia
- Hypernatremia
- Hypertension
- Blood pressure and mortality among hemodialysis patients
- A randomized trial of intensive versus standard blood-pressure control
- Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients
- Blood Pressure Measurement: Clinic, Home, Ambulatory, and Beyond
- Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis
- Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial
- Effects of an angiotensin-converting–enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
- Effects of intensive blood-pressure control in type 2 diabetes mellitus
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
- Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
- Pharmacotherapy for mild hypertension
- Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
- Resistant Hypertension: Core Curriculum 2008
- Stenting and Medical Therapy for Atherosclerotic Renal-Artery Stenosis
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
- The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study
- Treatment of Hypertension in Patients 80 Years of Age or Older
- Hypokalemia
- Hyponatremia
- Inherited Kidney Disorders
- Lipids
- Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
- Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
- Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
- Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- Lupus
- Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the lupus nephritis assessment with rituximab study (LUNAR)
- Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
- Sequential therapies for proliferative lupus nephritis
- Ten common mistakes in the management of lupus nephritis
- The classification of glomerulonephritis in systemic lupus erythematosus revisited
- Peritoneal Dialysis
- Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group
- Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes
- Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial
- General Medical Care of the Dialysis Patient: Core Curriculum 2013
- Randomized, Controlled Trial of Glucose-Sparing Peritoneal Dialysis in Diabetic Patients
- Polycystic kidney disease (ADPKD)
- Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease
- Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
- Tolvaptan in patients with autosomal dominant polycystic kidney disease
- Volume progression in polycystic kidney disease (CRISP)
- Potassium
- A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia
- An integrated view of potassium homeostasis
- Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial
- Hyperkalemia in Patients With Chronic Renal Failure
- Hypokalemia
- Italian society of nephrology: Management of HK in Kidney disease
- Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors
- Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate
- Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
- Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study
- Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age
- Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia
- Sodium zirconium cyclosilicate in hyperkalemia
- Renal Transplantation
- Donor-specific antibodies in kidney transplant recipients
- Immunosuppressive Drugs for Kidney Transplantation
- Immunosuppressive Medications
- Long-term consequences of kidney donation
- Long-term risks for kidney donors
- Rabbit antithymocyte globulin versus basiliximab in renal transplantation
- Recurrent glomerulonephritis after renal transplantation: an unsolved problem
- Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
- Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus
- Understanding crossmatch testing in organ transplantation: A case-based guide for the general nephrologist
- Vasculitis
- A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies
- A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies
- Efficacy of remission-induction regimens for ANCA-associated vasculitis
- Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
- Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis
- Rituximab versus cyclophosphamide for ANCA-associated vasculitis
- ADPKD Providers
- ADPKD - Clinics
- Regional Kidney Wellness Centre
- SARP ADPKD Clinic
- The Ottawa Hospital Eastern Ontario Cystic Renal Disease Centre of Excellence
- MUHC PKD Clinic
- Clinique PKR HDQ
- Lakeridge ADPKD Clinic
- University Of Alberta ADPKD Clinic
- Protection Renale, Hopital De Verdun
- PKD clinic
- ADPKD Clinic
- Institut de Recherches Cliniques de Montréal (IRCM)
- Surrey PKD Clinic
- Algoma Regional Renal Program
- Windsor ADPKD Clinic
- Kidney Care NHS
- Unité de recherche clinique - Hopital Sacré-Coeur
- Seven Oaks Hospital Nephrology Clinic
- Hamilton Kidney Genetics Clinic
- Chu Georges L. Dumont
- Abbotsford Kidney Care Clinic
- Clinique Régionale Rénale de L’outaouais
- Regional Kidney Wellness Centre
- QEII Health Sciences Centre
- Nephro Care Clinic
- Regional Kidney Wellness Centre
- SickKids Renal Genetic Clinic
- Clinique de protection rénale de Châteauguay
- Mackenzie Health
- Saskatoon Nephrology Group
- Hôpital Régional d’Edmundston Clinique Des Maladies Rénales/ Renal Disease Clinic
- VGH Kidney Care Clinic
- Hereditary Kidney Disease Clinic
- St Paul's Hospital PKD Clinic
- Saint John Regional Hospital
- Dr Bharat Nathoo
- Royal Inland Hospital Kidney Clinic
- Clinique de Néphrologie
- Clinique DEVENIR
- Scarborough and Rouge Hospital
- ADPKD - Physicians
- Dr. Louise Moist
- Dr. Sheldon Tobe
- Dr. Sanjay Pandeya
- Dr. Siva Thanamayooran
- Dr. Amy Nistico
- Dr. Tanya Shulman
- Dr. Eliot Beaubien
- Dr. Ilan Lenga
- Dr. Jeff Zaltzman
- Dr. Siva Karunakaran
- Dr. Arsh Jain
- Dr. Bonnie Richardson
- Dr. Sharn Bhandhal
- Dr. Michael Wang
- Dr. Adam Cohn
- Dr. Paul Watson
- Dr. Andrew Steele
- Dr. Thomas Hewlett
- Dr. Bhanu Prasad
- Dr. Faisal Rehman
- Dr. Kym Jim
- Dr. Phil McFarlane
- Dr. Jordan Weinstein
- Dr. Sean Murphy
- Dr. Charles Wei
- Dr. Jocelyn Garland
- Dr. Vishwanath Mahabir
- Dr. Nancy Barrese
- Dr. Gordon Yeung
- Dr. Micheli Bevilacqua
- Dr. David Weinstein
- Dr. John Paul Harmon
- Dr. Laura Pilozzi-Edmonds
- Dr. Shivinder Jolly
- Dr. Danny Sapir
- Dr. Derek Benjamin
- Dr. Mayur Govind
- ADPKD - Clinics
- Ukidney's Nephrology Ask the Expert Discussions
- Hypertension Questions
- Are there any major changes expected in the CHEP 2012 guidelines?
- CKD and Hypertension
- Combination therapy in Hypertension
- HTN management
- primary hyperaldostronism
- What is the difference between different types of angiotensin receptor blockers?
- Where do you use ACE inhibitors versus ARBs in treating hypertension
- General Nephrology Questions
- VERY HIGH CREATININE LEVEL
- (1) Albumin-Creatinine ratio (2) Kidney Failure
- 24 Hour urine results not good, but blood work good? Help?
- 24 urine result
- 25 yrs old egfr >59
- 28 month old infant with severe hydronephrosis - urgent recommendations required.
- 3 + protein in urine. should i be concerned ... very worried
- 3D Printers and Kidney Transplants
- A case of crescentic IgA
- A question about labs...
- Abnormal Urine test
- Abnormally high urea and creatinine
- Abnormally low urine creatinine, and unable to calculate Albumin/Creatinine Ratio (urine albumin less than the lower limit)?
- About renal cortical cyst on kidney
- Accurate determination of GFR
- acetaminophen alcohol nephrotoxicity
- ACR 0,9 but Albumin 29?
- ACR 300 mg/g
- ACR Range
- ACR results
- ACR Vs AMR
- Acute decline in kidney function (eGFR 25; Cr 179)
- acute renal failure
- adding on spironolactone for proteinuria should it be more universal?
- ADPKD
- ADPKD and liver disease
- Adult-hypertension-cretanine level and protien discharge is high.
- advice needed to avoid dialysis, stage 4 ckd with diabetes
- Alb/Creat Ratio
- Alb/Creat Ratio
- Albium Creatanine ratio
- Albumin level
- Am I beginning to feel the symptoms of kidney Diseases?
- Am i considered to have ckd?
- An anxious mother for her daughter
- ANCA ASSOCIATED GN
- ANCA MEDIATED CRESCENTIC GN
- Antibiotics and PD
- Any kidney issue/disease?
- approach to resistant cases of FSGS
- APR 2306
- ARBs in hyperkalemic patient
- Are these urine results of concern?
- ASA and Plavix use
- Aspirin low dose effects on kidneys
- Atrophic Left kidney, and Hydronephrosis in the right kidney
- Atypical anti-GBM disease
- atypical HUS
- Best book on acid- base and electrolytes
- Best osteoporosis medication for patient with reduced kidney function
- Biologic drugs in patients with renal disease
- Biopsy
- Borderline Kidney Function-Drugs or Lupus?
- Broad range in GFR/Creatinine values, some opinions on
- C4d staining in AMR
- Can a person with one functioning kidney participate in high impact contact sports?
- Can biologic medications be used in patients with chronic kidney disease?
- Can I excercise?
- Can I start gym with one kidney?
- Can I use topical NSAID cremes or marijuana creams?
- can you pls suggest what does these results infer
- catheter related infections
- CKD for children
- CKD stage 4/5
- CKD? Fluctuations in GFR and Creatinine
- Cloudy/Turbid Urine
- CNI induced TMA
- Cold or Flu treatment for a Stage 3 PKD patient
- compliments evaluation
- Concerned about blood work
- Confused
- Contract Induced Nephropathy?
- Could this still be Alports?
- Cramps on dialysis
- Creatine Level and Lithium
- Creatinine 3.1
- Creatinine calculations
- Creatinine high
- Creatinine increase
- Creatinine increases quickly
- Creatinine level 5.89
- Creatinine level after Radical nephrectomy
- Creatinine level high; ACR ratio under control
- Creatinine Levels
- Creatinine Levels
- Creatinine Levels of 1.38, BUN 9, Male 26, Weight 140
- Creatitine
- cryoglobulinemia and proliferative GN
- Decreasing GFR
- Diabetic Kidney Funtion
- Diets contradict for Kidney failure with type 2 Diabetes
- different eGFR calculation
- diltiazem antiproteinuric effect vs adverse effects
- Early post transplant oliguria, hypertension and hyperkalemia?
- Eculizumab and aHUS
- Effect of serum bilirubin on creatinine estimation.
- Effect of severe Hypo albuminemia and Massive proteinuria on falsely lowering eGFR and falsely lowering Serum Creatinine?
- EGFR
- eGFR
- eGFR of 59, does this mean I have CKD? How concerned should I be?
- eGFR over time
- Elderly man with very high proteins in urine
- Elevated ALT kevel in blood and lower creatinine in urine
- Elevated EGFR
- ERYTHROCYTES AND NEUTROPHILS HIGH
- Erythropoietin and renal cysts
- Etiology of AKI based on Labs?
- Excessive urination after rhabdomyolysis
- Ezetimibe for lipid reduction in Chronic Kidney Disease
- febrile rash with renal failure
- Fighting as a transplant recipient
- Finding a Dietician or Nutritionist
- Fluctuating Creatinine After 10 years of Kidney Transplant
- Fluctuating serum creatinine
- Fluimucil for Nephritis patient
- Foam in urine but no protein found.
- Foamy dark brown urine
- Foamy Urine
- Foamy urine
- Foamy urine
- foamy urine at a young age
- Foamy urine at morning
- Foamy urine for probably a year?
- Foamy urine in morning
- Foamy Urine, Negative dipstick
- Foamy urine.
- For fellowship in nephrology
- frequency of dialysis
- Frothy urine
- GADOLINUM CONTRAST & HYPOCALCEMIA?
- Gfr
- GFR 86
- GFR level after Radical Nephrectomy
- GFR of 59 ml/min, reason for concern?
- glomerulonephritis and plasma proteins
- Gross Hematuria
- had med exam for life insurance.all levels in normal range except very high 133 protein levels. help
- heamangioblastoma
- hearing loss due to renal tubular acidosis
- Hi
- Hi ACR results need some help please
- High Creatinine blood level
- High creatinine levels
- High Microalbumin/creatinine
- High urea : creatinine ratio in an overloaded patient
- Higj creatinine levels in type 1 diabetic patient
- How immunosuppression during active infection should be managed?
- How to improve my kidney profile?
- How to reduce creatinine level
- Husband went for urine test for medical examination report form
- Hyperphosphatemia , Hyperparathyroidism in dialysis
- Hypophosophotemia and hypercalcemia
- Hypothyroidism and CKD
- hypoxia
- I am a 45 yr old female, just diagnosied with stage 3 PKD (GFR 59). I also have hypertension. And cannot find a doctor with answers.
- Ibuprofen
- IgA Nephropathy
- IgNa
- Immune System support
- Immunosupression in kidney transplantation
- Impact of low Creatinine on ACR.
- Inactive ANCA Vasculitis
- Incidental hematuria
- Insulin Dependent Patient.
- Intestinal nephritis as a result of Mesalazine
- iron dosing in hemodialysis patients
- Is anyone in Toronto treating PKD with Tolvaptan?
- is clinidipine underused medication??
- Is it time
- Is it time to see a Nephrologist?
- Is there a problem with my kidneys?
- isosorbide dinitrate
- Just got bad labs
- kidney
- Kidney damage
- Kidney failure shortly after transplant; not rejection
- Kidney function
- Kidney function and Antihypertensives - acceptable decrease?
- kidney function and bone metabolism
- Kidney issues but no diagnoses???
- Kidney problems?
- Kidney readings
- Kidney related questions
- Kidney size variability
- Kidney Stone
- Kidney test
- Kidney transplant problem
- Lab test shows 703 Microalbum. Home dipstick test perhaps different?
- Lab unable to calculate
- Laboratory unable to calculate ratio for urine albumin:creatinine ratio and urine alubumin less that detection limit. What does this mean?
- Left kidney atrophy
- Lesion on kidney
- Light chain deposit disease and dialysis
- Losing Protein, but Why?
- Low complemets and liver disease w/o cryoglobulins?
- Low Creatine
- Low creatinine in urine
- Low protein/creatine
- Lupus Nephritis
- Membranous glomerulonephritis with gross hematuria
- Membranous Nephropathy
- Membranous nephropathy
- Microalbumin concern
- microalbumin/creatinine ratio not calculated?
- microalbuminuria and cardiovascular disease
- Microalbuminuria Test and Creatinine Blood Test
- Microscopic hematuria With pre-existing Ckd. Next step?
- minimal change disease
- Minimal change disease
- MPGN type 1
- Mr
- muddy brown casts
- My U Micro Alb/CREATU is high. Can you tell me what that means?
- My wife kidney/urine test
- Need an advice please?
- Need an expert guidance
- Negative serum creatinine via Modified Jaffe Method
- Nephrogenic ascites
- Nephrotic syndrome in a patient with recent malignancy
- Normal but increasing creatinine
- One time abnormality in my Creatinine and BUN and UREA
- Oral hypoglycaemic agents in Diabetic Nephropathy
- Painless Papilledmea, loss of visual acuity in CKD stage 4
- Patient with frequent relapse of MCD who responded to Rituximab
- peritoneal dialysis
- Permcath insertion length
- Persistent proteinuria
- Persistently Foamy / Bubbly Urine
- Pheo question
- Physical Training with Kidney Disease
- PLASMA PROTEINS
- Plasmapheresis formulation
- Polymyositis and dermatomyositis in relation with CKD
- Possible inadvertent transplant of donor kidney with Fabry's?
- post strep-glomerulonephritis but still blood in urine after one year
- Post transplantation HCV management
- posterior urethral valves (PUV)
- Pregnancy in Renal Transplant
- primary membranous nephropathy
- Probable kidney disease?
- PROTEIN IN URINE
- Protein in urine
- Protein in urine (18 years old)
- Protein in Urine and supplements after excercise
- Protein in urine since childhood
- Protein trace
- Protein/Creat number is high. Advice please.
- Proteinuria
- proteinuria VS rising creatinine level when using ACEI
- PSGN with Gross Hematuria over a Year later
- Quantification of proteinuria.
- Question - lab results, post stopping creatine
- Question about calcium containing phosphate binders
- Question about lab results please
- Question about labs
- Raised ACR and microhaematuria
- Random Urine test
- ratio of urea and creatinine
- RE: VERY HIGH CREATININE LEVEL
- RE: eGFR of 59, does this mean I have CKD? How concerned should I be?
- RE: Laboratory unable to calculate ratio for urine albumin:creatinine ratio and urine alubumin less that detection limit. What does this mean?
- RE: Tips for Reducing Serum Creatinine and increasing eGFR
- renal transplant
- Renal tubelar acidosis and vitamins
- resistant hypertension with polycystic kidney disease
- restarting peritoneal dialysis
- Results from recent blood and urine test
- Rising Creatinine levels
- Role of AVF inCKD and ESRD in the progression of Idiopathic Pulmonary HTN
- Role of oral hypoglycemics
- Salt restriction and 24 hour urine sodium
- Scared of kidney damage
- serum creatinine levels is high
- Serum Phosphorus and serum Potassium in ckd stage 3A
- SERUM URIC ACID AND CKD
- Should I be concerned with results?
- Should I be seen by a Nephrologist?
- Should I be worried
- Should i be worried
- Should I lift weight light weights and practice Martial Arts with one kidney?
- should we start dialysis?
- Simethicone
- Simple Kidney Cyst, Hi Crea, Low GFR
- Single kidney
- Single Kidney and creatinine
- Stage 1 or Stage 3 KFD
- Stage 4 CKD Prognosis
- Strange creatinine, protein in urine, and GFR fluctuations.
- Test and what it means
- the next step ?
- Timing the Aspirin and Statin doses
- Tips for Reducing Serum Creatinine and increasing eGFR
- Toddler with white granules in morning urine... PLEASE ADVICE!!
- Too much lab work - CKD or Not
- Trace of protien in urine
- Trace protein on dipstick, some from in urine.
- Trace urine
- transitioning from hemo to CAPD ascites not from liver failure ,How to treat, and train ?
- Transplant crossmatch
- Treatment of crecentric IgA Nephropathy
- Tunneled IJV catheter insertion in a patient with implantable cardioverter-defibrillator
- uACR result please respond sir.
- Unable to calculate Albumin/Creatinine Ratio
- Unable to calculate Albumin/Creatinine Ratio
- Uncontrolled hypertension
- Underdevoped kidney/ adrenals
- Urinalysis
- Urinalysis test results
- Urinalysis test results
- Urinary NGAL and acute renal failure
- Urine albumin creatinine ratio
- Urine analysis result
- Urine creatinine
- Urine Dipstick Accuracy
- Urine micro albumin
- Urine output on hemodialysis
- Urine results constant urge to urinate
- Urine test
- Validity of albumin to Cr ratio in case of raised serum Cr
- Veltassa vs. ZS-9
- Very High ACR and Urine Analysis
- Very high Plasma Renin Activity, more than 10 times reference range limit.
- Weight lifting with one kidney
- What can I do to reduce protein in my urine and restore my kidneys.
- what do the test results mean?
- What Do These Numbers Mean?
- What does high Alb/Creat Ratio mean ?
- What is a normal Leukocyte Esterase level in urine?
- What is microalbuminuria?
- What is the importance of the albumin to creatinine ratio (ACR)?
- What is the nephrology appointment frequency recommended in ckd for stages 1-2-3-4-5 and if I can find it in the litterature
- What should I do regarding kidney pain and foamy urine
- What urine test to be done
- WHY is SIMETHICONE unsafe for a person with POLYCYSTIC KIDNEY, who iscon DIALYSIS
- Will i survive long with bad diabetes kidney disease and no medication?
- Worried i have Kidney Disease
- Worried of High Renin Result
- Worried of Very High Renin
- Worried--daughter maroon urine
- Would you biopsy him?
- Complement Dysregulation
- Polycystic Kidney Disease
- Combination treatment for ADPKD?
- First line hypertension medications for PKD, ACEi/ARB?
- hello dr, creatine level 471 umol/L Yrea 22.6mmol/L, is this an indication that patient need kidney dialysis?
- How are you dealing with liver enzyme rise on Tolvaptan
- Polycystic kidney
- Tolvaptan for later stage CKD
- total kidney volume
- Unilateral polycystic kidney disease?
- urine creatine
- Which antidepressants are recommended for PKD patients?
- Fluid & Electrolyte
- Peritoneal Dialysis
- Hemodialysis
- Access recirculation
- acute haemodialysis
- Can I use prismaflex machine to perform chronic intermittent hemodialysis?
- extrapulmonary TB
- High cretetine level for kidney
- intradialytic hypotension
- Itching is in a hemodialysis patient
- Locking solution for dialysis catheters
- medication clearance with on line HDF
- Medication Reconciliation
- Urination while on hemodialysis
- which key ion is regulated by the kidney during acid base balance?
- Metabolic Bone Disease and SHPT
- Hypertension Questions
- General Nephrology Presentations
- 2018 Toronto ADPKD Scientific Conference
- Interactive case-based learning in ADPKD
- Diabetes management and chronic kidney disease
- Subsequent entry biologics: what are they and why are they?
- 2017 Toronto Polycystic Kidney Disease Scientific Day
- SGLT2 inhibition in diabetic kidney disease
- Hepatitis C: Can we eliminate a cause of CKD
- Why hepatitis C matters in patients with chronic kidney disease?
- Fabry disease: What every nephrologist should know
- Journée québécoise de la dialyse 2016 (JQH)
- eGFR and Microalbuminuria
- Dialysis for Poisonings
- Vasculitis and RPGN
- Pulmonary-renal syndrome
- Renal pathology
- Hypertension in pregnancy
- Renal cell carcinoma
- Nephrogenic fibrosing dermopathy
- Kidney stone prevention
- Edema states and diuretics
- Regulation of sodium excretion (Part 1)
- Renal sarcoidosis
- 2017 Polycystic Kidney Disease (PKD) Symposium
- Chinese herb nephropathy
- Renal artery stenting: Indications and end-points
- Electrolyte management in the Elderly
- Surgical management of kidney stones
- Highly active anti-retroviral therapy complications: a Nephrology Perspective
- Lupus Nephritis
- Lithium induced diabetes insipidus
- Pulmonary renal syndromes in the ICU
- Vaptans: Possible treatment for hyponatremia
- Hepatitis C and renal disease
- Wegener's granulomatosis
- Tubulointerstitial nephritis and uveitis (TINU): Case discussion
- Combining medications in the management of hypertension
- Microalbuminuria testing
- Nephrogenic systemic sclerosis: Update 2009
- Pregnancy in hemodialysis patients
- Acid Base Physiology Update CSN Review Course 2009
- Cardiorenal axis: Preventing and Treating diabetic nephropathy
- Syphilis and renal disease
- Prevention of nephrotoxicity of the chemotherapeutic agent
- Very old persons with chronic kidney disease: is Dialysis harmful?
- Vexing Cases in Lupus Nephritis
- The role of Vitamin D for the prevention of diabetes mellitus and diabetic nephropathy
- Pitfalls in estimating renal failure in the elderly by eGFR
- Dual RAAS Blockade: Rationale and Literature Overview
- Renal Sparing Strategies in Renal Cell Carcinoma
- Managing elderly persons with CKD stages 3-4
- Prenatal determinants for maximum nephron endowment at birth
- Membranous Glomerulonephritis - Dr D Cattran
- Prevention of IgA Nephropathy
- Prevention of Focal Segmental Glomerulosclerosis
- Hepatitis C Glomerulonephritis
- HIV-Associated Kidney Disease
- Paraproteinemias (myeloma - amyloidosis)
- Coping with the Difficult Patient
- Sleep Disorders in Patients with Chronic Kidney Disease
- Supramaximal Dose of Candesartan in Proteinuric Renal Disease
- Proteinuria reduction with ARBs: The DROP Study
- IDNT and IRMA II Trials and Proteinuria Reduction
- Aggressive RAAS blockade should we change practice
- Sickle Cell Anemia and Renal Disease
- Amphotericin B Nephrotoxicity
- Diet and Kidney Stone Prevention
- Continuous Renal Replacement Therapy
- New innovations in Gout: Febuxostat
- Is diabetic nephropathy more than one disease?
- Is there a role for endothelin blockade in diabetic nephropathy?
- Prevention of renal disease in pregnant women with lupus
- Prevention of renal disease in Spina Bifida
- Prevention of progression of IgA nephropathy - the paediatric perspective
- A female with thrombocytopenia and thrombotic Microangiography
- A patient with diabetes, hepatitis C and nephrotic syndrome
- Molecular Mimicry
- A Decade of Progress in Lupus Nephritis
- Membranous nephropathy
- Transition of Pediatric Patients to Adult Nephrology
- Rare pediatric diagnoses now surviving into adulthood
- Transition of Pediatric Patients to Adult Nephrology: Views of an adult Nephrologist
- Diabetic nephropathy - primary prevention and regression
- Prevention of AKI in the elderly
- Overcoming barriers to end-of-life decision making
- Proteinuria and cardiovascular disease
- Renal Disease and Protease Inhibitors in Aging HIV Patients
- Hyperlipidemia Management in CKD
- Proteinuria and cardiorenal outcomes
- Complement dysregulation in thrombotic microangiopathy and the emerging role of Eculizumab
- Volume expanding patients with hyponatremia
- ASN Board Review Course Coverage
- SGLT2 Inhibition: Questions and answers for an emerging therapy
- Journal Club: The use of Atrasentan to reduce proteinuria in diabetic nephropathy
- Journal Club: Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial.
- Anticoagulation in Kidney Disease: Options and Considerations
- Spotlight on microangiopathic hemolytic anemias and bone marrow failure syndromes: Concluding remarks
- Spotlight on microangiopathic hemolytic anemias and bone marrow failure syndromes: Pediatric cases
- Approach to a patient with MAHA and thrombocytopenia
- TMA case studies
- Autosomal Dominant Polycystic Kidney Disease (ADPKD) Wall of Experts
- ADPKD Speaking Volumes
- Clinical cases of cancer-associated thrombosis (CAT) in patients with renal dysfunction
- Nephrology in 2016: A year in review
- Hypertension Presentations
- Hypertension Canada Guidelines 2017 (for Specialists)
- Hypertension Canada Guidelines 2017 (for Primary Care)
- Assessing patients with hypertension
- Treating hypertension
- BP measurement
- Lifestyle management
- Promoting treatment adherance
- Severe Hypertension
- BP management and diabetic nephropathy
- Microalbuminuria and CV disease
- Hypertension and CKD
- Hypertension management with focus on direct renin inhibitors
- Current Trends and Controversies in the Diagnosis and Treatment of Hypertension
- Reducing Cardiovascular Disease and Renal Disease by Treating Proteinuria
- Hypertension Management in Type 2 Diabetes
- Can BP control prevent renal damage?
- Hypertension 2010: Principles of Management
- Combination Treatment of Essential Hypertension
- 2014 CHEP Hypertension Treatment Recommendations
- Hemodialysis Presentations
- Home Dialysis Lecture Series Session 6: Knowledge Application - The Cases
- Home Dialysis Lecture Series Session 5: Home Hemodialysis Vascular Access
- Home Dialysis Lecture Series Session 4: Home Hemodialysis Patient selection & Trainin
- Home Dialysis Lecture Series Session 1: Patient Selection
- Urea kinetics
- Dialyzers and dialysis machines
- Hemodialysis adequacy
- Non-infectious complications of HD catheters
- Past, present, future of hemodialysis
- Blood volume monitoring and sodium profiling in HD
- Home and nocturnal hemodialysis
- Acute complications of hemodialysis
- Hemodialysis access emergencies
- Prevention of Intradialytic Hypotension
- Conservative management vs. dialysis in the elderly patient with stage 5 CKD
- Pregnancy in women on dialysis
- Withholding or withdrawing dialysis
- Existential psychotherapy in end of life care
- Atlas of Dialysis Vascular Access
- Rational approach to vascular access in the elderly
- Prevention of RRF loss in dialysis patients
- Physical Examination of Arteriovenous Fistula
- Portable Ultrasound for Hemodialysis Access Assessment and Cannulation
- Journée Québécoise d'hémodialyse 2015 (JQH)
- Peritoneal Dialysis Presentations
- Home Dialysis Lecture Series Session 3: PD Prescriptions & Complications
- Home Dialysis Lecture Series Session 2: PD Catheters 101
- Primer of peritoneal dialysis
- Ultrafiltration failure in PD
- Preservation of renal function
- Noninfectious complications of PD
- Infectious complications of PD
- PD in acute renal failure
- Peritoneal dialysis in the elderly
- Challenging cases in peritoneal dialysis
- Overview and physiology of peritoneal dialysis
- Adequacy of Peritoneal Dialysis
- Peritoneal dialysis: Video Preceptorship
- Update in Peritoneal Dialysis CSN Review Course 2009
- Growth of Peritoneal dialysis: Impact of home assistance
- Controversy of biocompatible solutions in peritoneal dialysis
- Prevention of Peritoneal Dialysis-related infections
- The Importance of Residual Kidney Function For Patients on Dialysis, Dr. Jeffrey Perl
- Peritoneoscopic Insertion of a Peritoneal Dialysis Catheter
- Introduction to PD Catheter Insertion Methods
- Interventional Radiology and Peritoneal Dialysis
- Blind bedside insertion of PD Catheters
- The Embedded Peritoneal Dialysis Catheter
- Peritoneal Dialysis Adequacy
- Non-infectious complications of Peritoneal Dialysis
- The Physiology of Peritoneal Dialysis
- The Importance of Residual Kidney Function For Patients on Dialysis
- Diagnosis of Encapsulating Sclerosing Peritonitis
- Encapsulating Sclerosing Peritonitis: Radiological perspective
- Prevention of sudden death in the dialysis patient
- Prevention of peritonitis in patients on PD
- PD Access Triage and the Role of a PD Access Coordinator
- Post-Implantation Management of PD Catheters
- Buried PD Catheters
- PD Catheter Insertion Techniques
- PD Catheter Insertion: The Surgeon's Perspective
- Approach to Malfunctioning PD Catheters
- PD Catheter Insertion: The Radiologist's Perspective
- PD Catheter Insertion: The Nephrologist's Perspective
- Access Complications: PD vs. HD
- Indications for PD Catheter Removal
- PD Catheter Types and Clinical Outcomes
- Chronic Kidney Disease
- Essential Concepts in Chronic Kidney Disease
- Biology of uremia: Vascular disease
- Detection, monitoring and referral of chronic kidney disease
- Pulmonary hypertension in end-stage renal disease
- Prevention of Chronic Kidney Disease in patients with disorders of the complement system
- Sudden Death in Chronic Kidney Disease
- A Trial of Care for CKD: Can-Prevent
- EMiNEM: Education in Mineral Metabolism
- Essential concepts in chronic renal failure
- Renal Anatomy and Physiology: a foundation for learning about chronic renal failure
- Cardiovascular complications of chronic kidney disease
- Renal anemia
- Chronic Kidney Disease: Overview
- Bone and Mineral Metabolism and Disease in CKD
- The Impact of Phosphate Food Additives in Chronic Kidney Disease
- The relevance of the attachment system for adapting to chronic illness
- Haemoglobin: A moving target in CKD Patients
- The TREAT study: prevention of Anaemia in Diabetic Patients with CKD - Dr. Patrick Parfrey
- Interventions in ESRD/CKD patients with cardiac Disease - Dr. Patrick Parfrey
- Is there role of statins in cardiovascular protection in CKD patients stages 3-4 - Dr. Marcello Tonelli
- Sexual function and quality of life in patients with CKD
- Screening and treatment of sexual dysfunction in patients with CKD
- Prevention of long-term sequelae of pre-eclampsia
- Detecting CKD in the elderly: When a decreased eGFR is CKD
- Is renoprotection worthwhile in the elderly patient with hypertension and/or CKD
- Prevention of cardiovascular morbidity in adolescents with childhood onset CKD - Dr. Rulan Parekh
- Psychological concepts in sexuality in patients with renal disease
- Beta Blockers in Chronic Kidney Disease
- Kidney Health - Spreading the Word
- The role of hyperuricemia in CKD
- Chronic Kidney Disease and Osteoporosis: How to Diagnose and Treat
- Sex hormones and progression of CKD
- Chronic Kidney Disease Web Series
- Fractures across the spectrum of CKD
- Renal Transplantation Presentations
- Using organs from high risk donors
- Renal transplant surgery
- Fungal infections in transplantation
- Hypertension after renal transplant
- Transplant emergencies
- Viral infections in renal transplantation
- Essentials of live kidney donation
- Overview of renal transplantation
- Kidney Pancreas Transplantation
- Immunosuppressive Medications
- Tissue typing and cross-matching in kidney transplantation
- Hepatitis B in renal transplant recipients
- BK Polyoma virus infection in renal transplantation
- Commercial transplantation
- Essential clinical issues in renal transplantation
- Prevention of nephrotoxicity of immunosuppressive agents in kidney transplantation
- Living donor assessment and long-term complications
- Statins and RAS blockade in prevention of kidney disease in kidney transplantation
- Transition of Pediatric Renal Transplant Patients to Adult Nephrology
- Prevention of late immunologically mediated chronic kidney allograft injury
- Prevention of non immunologically mediated chronic kidney allograft injury
- Update in Pancreas Transplantation
- Bone and Mineral Metabolism Presentations
- Vitamin D in chronic kidney disease
- Overview of bone and minreal metabolism
- Hyperparathyroidism - Focus on calcium
- Vascular calcification in CKD
- Biology of uremia: Calcium, Phosphate and Vitamin D
- Fosrenol: An overview of a new phosphorus binder
- Vascular calcification symposium 2009
- Renal Osteodystrophy: What's New
- The Importance of Vitamin D
- Latest Developments in Bone Mineral Metabolism
- Learning From Images in Nephrology
- Dysfunctional Dialysis Catheter
- Vascular Extension from an Infiltrating Renal Tumor
- Renal Volume in Polycystic Kidney Disease
- Seroma Related to Prosthetic Arteriovenous Graft
- Staghorn Calculi
- Hemodialysis Catheter Misadventure: Can We Prevent This Fundamental Mistake?
- Aneurysmal Dilatation of Dialysis Arteriovenous Access
- Hand Pain with Dialysis Access: Is it Always Steal Syndrome?
- Transplant Renal Artery Stenosis
- Perinephric Lymphoma
- Arteriovenous fistula stenting: Size matters
- Frosty Man
- Yin-yang sign in arteriovenous fistula pseudoaneurysm
- Fundamental Mistake During Tunneled Hemodialysis Catheter (TDC) Removal
- Encapsulating Peritoneal Sclerosis
- Toxicology
- Thrombotic Microangipathy
- Vimeo
- The intersection between complement and coagulation
- Case studies in thrombotic microangiopathy
- TMA Pathogenesis
- TMA: A case example
- Complement involvement in STEC-HUS: Clinical observations
- State of the art on aHUS
- Practical TMA work-up
- Role of renal biopsy in TMA management
- Genetics and aHUS: State of the art and clinical application
- Biomarkers of endothelial injury: Practical aspects
- State of the art on TTP
- TMA: View from Microscope
- Understanding Complement Testing
- aHUS What we have learned in the past 20 years
- Approach to a patient with MAHA and thrombocytopenia
- Spotlight on microangiopathic hemolytic anemias and bone marrow failure syndromes: Pediatric cases
- Spotlight on microangiopathic hemolytic anemias and bone marrow failure syndromes: Concluding remarks
- Complement dysregulation in thrombotic microangiopathy and the emerging role of Eculizumab
- Advances in Patient Management
- Challenges in Differential Diagnosis TMAs
- Glomerular Diseases to Organ Damage
- Coagulation and Complement
- Role of Complement in Transplantation
- TMA Clinical Work Up
- TTP Update
- Management and Outcomes of Secondary TMAs
- TMA and pregnancy
- General Nephrology Videos
- Renal Transplantation Videos
- Peritoneal Dialysis Videos
- Renal Pathology Videos
- Histopathology Kidney - Systemic lupus erythematosus
- Histopathology Kidney - Acute tubular necrosis from ethylene
- Histopathology Kidney - Rapidly progressive glomerulonephritis
- Histopathology Kidney - Interstitial nephritis
- Histopathology Kidney - Arteriolosclerosis (hypertension)
- Histopathology Kidney - Adult polycystic disease
- Histopathology Kidney - Acute and chronic pyelonephritis
- Histopathology Kidney - Wilms tumor
- Histopathology Kidney - Transitional cell carcinoma
- Histopathology Kidney - Renal cell carcinoma
- Histopathology Kidney - Septic infarct
- Histopathology Kidney - Diabetic glomerulosclerosis
- Histopathology Kidney - Acute transplant rejection
- Histopathology Kidney - Acute tubular necrosis
- Histopathology Kidney - Membranous glomerulonephritis
- Hemodialysis Videos
- All Nephrology Manuals
- CSN Guidelines
- Calculators and Tools
- Nephrology News
- General nephrology
- ACE and ARB in combination: Still a viable option?
- Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
- Are calcium-based phosphate binders obsolete?
- ASH: Calcium Channel Blocker Benefits in ACCOMPLISH Not Explained by Ambulatory BP
- Bardoxolone in Chronic Kidney Disease: A major breakthrough?
- Bardoxolone study terminated over excess mortality
- Benlysta: Promising new Lupus drug on the horizon
- Calcium-based phosphate binders likely harmful in CKD
- Chloroquine in Lupus: Prevents flares and saves lives
- Cinacelcet and cardiovascular outcomes: neutral study underscores a fundamental problem in nephrology research
- Class Review of Phosphate Binders
- Dilemma for Dialysis Patients, Skinny is Dangerous
- Dream RCT: A placebo-controlled trial of hyperphosphatemia management
- eGFR and microalbuminuria: a powerful duo
- Empagliflozin and renal outcomes: further insights in to the renal protection of SGLT2 inhibitors
- Ezetimibe and Simvastatin in Chronic Kidney Disease: Good News
- Fascinating new therapy for PCKD on the horizon
- Generic drugs: a dangerous public misunderstanding?
- Growing new kidneys? An idea whose time may have come
- High cut-off hemodialysis for the treatment of multiple myeloma
- Hyperphosphatemia management - It is time for a randomized trial
- Important genetic link found for FSGS in African Americans
- INSPRA approved as adjunct to standard therapy to reduce risk of death
- Is rosuvastatin (Crestor) nephrotoxic?
- Jinarc (Tolvaptan) approved in Canada for the management of autosomal dominant polycystic kidney disease (ADPKD)
- KDIGO Bone and Mineral Guidelines now available
- More evidence for mycophenolate mofetil in lupus nephritis
- More positive news for Tolvaptan (Jinarc) in ADPKD: Reprise Study topline results
- MR elastography: Revolutionizing the assessment of renal fibrosis
- Racial/ethnic disparities in atrial fibrillation treatment and outcomes in us dialysis patients
- Removing a failed kidney allograft improves survival?
- Renal end-points in the ACCOMPLISH Study: Is it all hype?
- Renal outcomes with Empagliflozin: a game-changer
- SAVOR Trial Negative: No CVD advantage for Saxagliptin
- SGLT2 inhibitors and nephroprotection: a perspective on the renal outcome data
- Sirolimus and Everolimus in Polycystic Kidney Disease
- Sodium bicarbonate replacement delays progression of chronic kidney disease
- Statins in end-stage renal failure: failure revisted
- Tolvaptan in Polycystic Kidney Disease (ADPKD): the most exciting nephrology development in years
- Transplant Drug Two-Year Study Outcomes Show Superior Kidney Function
- TREAT Trial with Aranesp in patients with diabetes and chronic kidney disease
- Treating microalbuminuria to reduce cardiovascular disease: an increasingly dangerous strategy
- Vitamins are harmful in patients with chronic kidney disease
- Kidney transplantation
- Hypertension
- Angiotensin Receptor Blockers and Cancer
- Blood pressure targets called in to question? Yes and No
- Calcium channel blockers and breast cancer: an important risk factor discovered?
- Calcium channel blockers and breast cancer: Update
- Clinical Focus: How can I maximize blood pressure control for my patients and also minimize pill burden?
- Empagliflozin and renal outcomes: Further insights to a proven hypothesis
- Hypertension targets following the SPRINT study
- Hypertension Update: Did you know...
- No benefit of Aliskiren added on to ACE or ARB: a disappointing development
- Olmesartan delays the onset of microalbuminuria, but more deaths seen
- Racing to apply the SPRINT study to your practice? Not so fast
- Renal denervation safe, but fails to meet primary end-points in Symplicity 3
- The ACCORD Blood Pressure Study: The J-point realized?
- The importance of diuretic selection when managing hypertension
- Thiazide diuretics are not created equal, especially with the new ARB azilsartan
- Nephrology Education
- ASN Conference Update
- 24-hydroxylase deficiency: comparison with other disorders of vitamin D-mediated hypercalcemia
- A Transatlantic comparison in CKD care
- Adaptive and maladaptive kidney repair models reveal distinct pathways of myeloid and lymphoid cell recruitment and activation
- Adipose Tissue and Modulation of Hypertension
- An open-label extension study to evaluate the efficacy and safety of Roxadustat for the long-term maintenance treatment of anemia in dialysis and non-dialysis patients with CKD
- ASN Kidney Week 2019 Locks Onto the Future
- Canagliflozin in patients with very low GFR: Protection persists
- Effect of angiotensin-neprilysin inhibition on renal outcomes in heart failure with preserved ejection fraction
- Global Kidney Health Atlas: Why We Need It and How It May Affect CKD Worldwide
- Hot off the Press: The Advancing Kidney Health Initiative and More
- Keeping a close watch
- Planting a new seed of health
- Pooled efficacy and cardiovascular (CV) analyses of roxadustat in the treatment of anemia in CKD patients on and not on dialysis
- Racial/ethnic disparities in atrial fibrillation treatment and outcomes in us dialysis patients
- Reaching for better quality patient care
- The physiology behind the effect of exercise on hypertension and the kidney
- Vitamin D in CKD: Case Closed
- General nephrology
